An open question is whether other epitopes of p‐tau (such as 217 or 231) are more sensitive to intermediate ADNC than p‐tau181, especially at earlier AD stages,13, 44, 45, 47 including preclinical AD.48 The gene discussed is MAPT; the disease is Alzheimer disease.